MINSK, 4 March (BelTA) – The China-Belarus Industrial Park Great Stone has created all conditions for the development of a pharmaceutical cluster, Belarusian Deputy Economy Minister Tatiana Brantsevich said in her online greetings at a ceremony to donate Qingyi capsules made by Novoera Biotech to the Women's Union and the Hong Kong Industry Association, BelTA learned from the press service of the Economy Ministry.
"Qingyi, a traditional Chinese herbal medicine, was registered in Belarus at the end of last year. This medicine is designed to prevent and treat the effects of COVID-19," Tatiana Brantsevich said.
Tatiana Brantsevich recalled that pharmaceuticals and medical services have been identified as new priorities for Great Stone. The park offers an accelerated and simplified procedure for medicines registration and clinical trials, along with a well-developed system for training medical personnel and preferences for manufacturers. This makes it possible to develop a pharmaceutical cluster in the park.
"Building such centers and clusters within the framework of the Silk Road Economic Belt will enable us to make an effective use of the available resources of countries and their competencies, develop new technologies in the field of medicine and pharmaceuticals, contribute to the availability of medicines, and strengthen public health in general," Tatiana Brantsevich said.